Phage–meropenem synergy against multidrug-resistant Klebsiella pneumoniae biofilms: phenotypic and genomic characterisation of vB_KpnS_Tech
International Microbiology · 05.11.2026
DOI: 10.1007/s10123-026-00922-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Microbiology, online erschienen am 05.11.2026. Verfasst von Kashif Haq und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, School of Health Sciences, Birmingham City University, Birmingham, B15 3TN, UK. Kashif.haq@bcu.ac.uk. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing prevalence of multidrug-resistant (MDR) Klebsiella pneumoniae and its capacity to form persistent biofilms highlight the need for alternative antimicrobial strategies. This study characterised the lytic bacteriophage vB_KpnS_Tech (PQ859379.1) and evaluated its activity in combination with meropenem against established MDR K. pneumoniae biofilms of different maturities. vB_KpnS_Tech exhibited rapid adsorption, with 98.8% of phage particles adsorbed within 7.5 min, a latent period of approximately 30 min and a mean burst size of approximately 165 PFU per infected cell. The 49,562-bp genome had a GC content of 51.1% and contained 86 predicted coding sequences, including putative holin, endolysin and Rz-like spanin-associated lysis proteins. No recognised antimicrobial-resistance, virulence or lysogeny-associated determinants were detected by the applied genomic screens, and comparative analyses placed vB_KpnS_Tech within the family Drexlerviridae and genus Webervirus, within an existing species-level genomic cluster. Phage–meropenem checkerboard assays demonstrated a clear effect of biofilm maturity on treatment response. Maximum relative biomass reduction reached 66.0% in 24 h biofilms, while the selected combination of 1 × 10⁹ PFU/ml phage and 256 µg/ml meropenem produced reductions of 62.2% and 42.7% in 24 h and 48 h biofilms, respectively. Independent Bliss analysis of biological replicate checkerboards demonstrated synergy in 24 h biofilms, with a mean global score of 10.53 ± 0.53, whereas the interaction in 48 h biofilms was attenuated and remained within the additive/independent range (3.37 ± 0.88). The selected combination reduced recoverable viable bacterial burden by 2.60 and 1.70 log₁₀ CFU/ml relative to untreated endpoints in 24 h and 48 h biofilms, respectively, and reduced viable counts below corresponding pre-treatment baselines. Combination treatment was also associated with the greatest reductions in recoverable EPS-associated carbohydrate, extracellular protein and extracellular nucleic-acid material and retained activity against five additional phage-susceptible MDR K.pneumoniae isolates. Collectively, these findings demonstrate a concentration- and maturity-dependent phage–meropenem interaction and support further evaluation of vB_KpnS_Tech–meropenem combinations against established MDR K.pneumoniae biofilms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, School of Health Sciences, Birmingham City University, Birmingham, B15 3TN, UK. Kashif.haq@bcu.ac.uk.
- Department of Life Sciences, School of Health Sciences, Birmingham City University, Birmingham, B15 3TN, UK.
ORCID-Profile: Kashif Haq
Zitieren
APA
Haq, K., Figgitt, M., Lee, D., & Nadeem, H. (2026). Phage–meropenem synergy against multidrug-resistant Klebsiella pneumoniae biofilms: phenotypic and genomic characterisation of vB_KpnS_Tech. International Microbiology. https://doi.org/10.1007/s10123-026-00922-0
Vancouver
Haq K, Figgitt M, Lee D, Nadeem H. Phage–meropenem synergy against multidrug-resistant Klebsiella pneumoniae biofilms: phenotypic and genomic characterisation of vB_KpnS_Tech. International Microbiology. 2026. doi:10.1007/s10123-026-00922-0
BibTeX
@article{Haq2026,
author = {Haq, Kashif and Figgitt, Martin and Lee, David and Nadeem, Hasan},
title = {Phage–meropenem synergy against multidrug-resistant Klebsiella pneumoniae biofilms: phenotypic and genomic characterisation of vB_KpnS_Tech},
journal = {International Microbiology},
year = {2026},
doi = {10.1007/s10123-026-00922-0}
}
EUVIMED